日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Global Views

Profits of selfishness

By NKOLO FOé | China Daily Global | Updated: 2021-03-23 07:52
Share
Share - WeChat

West's buying up of vaccines not only supports Big Pharma but also its geopolitical goals

YAO ER/FOR CHINA DAILY

The health business is immensely profitable. And the profits to be made during the pandemic seem to have shattered all notions of solidarity and killed all feelings of compassion in some.

The COVID-19 vaccines offer profits par excellence. For example, Pfizer projects 2021 revenue of $15 billion and profits of $4 billion from its COVID-19 vaccine alone. Such profits have justified immoral conduct. Through corruption, the United States tried to steal the vaccine project from the Germans, the aim being to make the new product exclusively US.

But the words of Christian Lindner, chairman of the German Liberal Party, point to problem with the pursuit of profits at this time: "The fight against the novel coronavirus is a task that concerns all of humanity. There is no room for selfishness."

President Xi Jinping's proposal of a global community of health for all makes humanity as a whole the beneficiary, with solidarity as the weapon that can defeat the virus.

At the China-Africa Extraordinary Summit on Solidarity Against COVID-19 on June 17 last year, Africa supported China's efforts to preserve the United Nations-centered global governance system, which is being undermined by the liberal democracies of the West. The selfish motives for the US withdrawal from the World Health Organization are obvious: the US deprived the UN institution of 15 percent of its budget to guarantee Big Pharma supremacy in the global pandemic health market, without the unwanted obstacle of the multilateral institution's emphasis on equitability in access to vaccines and therapeutic treatments.

For a long time, the business of COVID-19 vaccines dominated debates within the WHO, before moving to the World Trade Organization. Countries that host vaccine-producing pharmaceutical laboratories require compliance with intellectual property rights agreements, in accordance with the Agreement on Trade-Related Aspects of Intellectual Property Rights.

The COVID-19 vaccines have rekindled the old controversy over the protectionism aimed at promoting and securing the vaccine monopolies of Big Pharma.

On Feb 17, Antonio Guterres, secretary-general of the United Nations, put forward the idea of a "Global Immunization Plan to bring together all those who have the power, the scientific expertise and the necessary productive and financial capacities", calling vaccine equity "the greatest moral test of our time".

But so far, progress on immunization has been unfair and uneven, with just a dozen countries, all from the North, having granted themselves the privilege of administering 75 percent of all COVID-19 available vaccines, according to the UN. That is why, independent experts from the UN have been pleading since March 1, for cooperation on vaccines within the WTO. The UN calls on rich countries to abandon narrow "vaccine nationalism"-vaccine apartheid harmful to the global economy-while urging the WTO to accept the necessary waivers on the Agreement on Trade-Related Aspects of Intellectual Property Rights.

The UN thus poses the question of who is upholding "the right to development for all". For the UN, the agreements of the WTO should not constitute an obstacle to access to vaccines and medicines. On the contrary, the agreement should facilitate the protection of public health in all countries and promote the accessibility of COVID-19 vaccines. The fact that most of the vaccines produced have gone to 10 rich countries is clearly immoral.

COVAX is an important step in the right direction. Created in April 2020, it is the product of the WHO, GAVI-vaccine Alliance and Coalition for Epidemic preparedness Innovations (CEPI). It comprises two essential mechanisms: one for purchasing vaccines and another intended for financing in favor of poor countries. But the financial commitments made do not prevent the rich countries from hampering universal accessibility to the vaccine as long as they reserve 80 percent of the vaccines, at least until 2022.

Vaccine equity is an issue that could have been solved within the framework of an intelligent policy of sharing responsibilities between the great powers. But the selfishness of the rich countries and the geopolitics of Western spheres of influence hinder the implementation of such a policy in Africa and prohibit the free access of African countries to the Big Pharma vaccines.

Spokeswoman of the Chinese Ministry of Foreign Affairs Hua Chunying said on Jan 20 that there is no need "to put on the vaccines an invisible geopolitical label", doing so is criminal and immoral. Given the gravity of the pandemic, "the putting into service of more vaccines, in particular in the developing countries, could have contributed greatly to our common fight against the virus".

China has declared its vaccines a global public good, and wants developed countries to share their vaccines with developing countries, as the West's favorite zero-sum game is counterproductive. Africa's position is clear: No power outside the continent should take advantage of the pandemic to destabilize states. A scenario heralded by a diplomatic note from the French Ministry for Europe and Foreign Affairs on March 24,2020, titled, "The Pangolin Effect: the storm coming to Africa?". Heralding a coming apocalypse, it predicted the collapse of societies due to the virus, enabling regime changes that would be accommodating to the West.

It is to prevent these developments that the COVID-19 vaccine must be made available, everywhere in Africa. It is the guarantee of health and stability.

The author is a full member of the International Institute of Philosophy in Paris and a member of the Consultative Committee of the China-Africa Institute at the Chinese Academy of Social Sciences. The author contributed this article to China Watch, a think tank powered by China Daily. The views do not necessarily reflect those of China Daily.

If you have a specific expertise and would like to contribute to China Daily, please contact us at [email protected], and [email protected].

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 哥斯拉大战金刚2在线观看免费完整版 | 五月婷婷婷婷 | 欧美三级网址 | 三上悠亚2022最新番号 | 一区二区高清视频 | 成片免费观看视频在线网 | 毛片性生活 | 欧美激情欧美激情在线五月 | 色播在线永久免费视频网站 | 中文字幕不卡在线观看 | 亚洲一区欧美日韩 | 成人性视频免费网站 | 久久激情av | 国产精品岛国久久久久久 | 国产精品美女一区二区三区 | 美女被网站大全在线视频 | 国产成人综合在线 | 一区二区三区日韩在线观看 | 精品福利视频在线观看视频 | 国产精品无码人妻无码色情多人 | 国产精品a久久久久 | 免费国产一区 | 美女久久久久久久久久久 | 久久久久久久99精品免费观看 | 韩国在线精品福利视频在线观看 | 日本污污视频在线观看 | 午夜影视在线观看免费完整高清大全 | 亚洲AV无码色情第一综合网 | 91成人影院未满十八勿入 | 久久电影精品久久99久久 | 久久久无码精品一区二区三区 | 另类五月天 | 中国一级特黄真人毛片免费看 | 中国免费毛片 | 亚洲尻逼视频 | 蜜桃av一区二区三区 | 精品国产欧美一区二区 | 国产在线观| 欧美久草 | 黄色片的网站 | 欧美男人天堂 |